Magazine | Pharma Business International

EDITOR PICKS

Gene editing with CRISPR used to treat lethal lung diseases in utero

Gene editing with CRISPR used to treat lethal lung diseases in...

18th April 2019

PureTech and BI to advance immune-oncology product candidates

PureTech and BI to advance immune-oncology product candidates

18th April 2019

Positive NICE recommendation for Tegsedi

Positive NICE recommendation for Tegsedi

18th April 2019

POPULAR POSTS

Phase III data for infliximab biosimilar published

Atlantis initiatives rolling submission for pouchitis treatment NDA

3rd May 2017

Vifor gains Asian commercialisation rights for rare renal diseases treatment

16th February 2017

New treatment developed for tuberculosis

AZ report positive results for lung cancer treatment

15th May 2017